{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T17:44:41Z","timestamp":1762623881675},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["mgmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.ymgme.2017.06.002","type":"journal-article","created":{"date-parts":[[2017,6,8]],"date-time":"2017-06-08T17:46:40Z","timestamp":1496944000000},"page":"140-147","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Functional and biological studies of \u03b1-galactosidase A variants with uncertain significance from newborn screening in Taiwan"],"prefix":"10.1016","volume":"123","author":[{"given":"Hsuan-Chieh","family":"Liao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting-Rong","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leslie","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuan-Chi","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Kai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao-Chuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dau-Ming","family":"Niu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yann-Jang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ymgme.2017.06.002_bb0005","doi-asserted-by":"crossref","first-page":"338","DOI":"10.7326\/0003-4819-138-4-200302180-00014","article-title":"Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy","volume":"138","author":"Desnick","year":"2003","journal-title":"Ann. Intern. Med."},{"issue":"4","key":"10.1016\/j.ymgme.2017.06.002_bb0010","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/jmg.2005.036327","article-title":"Natural history of Fabry disease in females in the Fabry Outcome Survey","volume":"43","author":"Deegan","year":"2006","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ymgme.2017.06.002_bb0015","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000060184","article-title":"Fabry disease (alpha-galactosidase A deficiency): renal involvement and enzyme replacement therapy","volume":"136","author":"Desnick","year":"2001","journal-title":"Contrib. Nephrol."},{"issue":"5","key":"10.1016\/j.ymgme.2017.06.002_bb0020","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1056\/NEJM199508033330504","article-title":"An atypical variant of Fabry's disease in men with left ventricular hypertrophy","volume":"333","author":"Nakao","year":"1995","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.ymgme.2017.06.002_bb0025","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1046\/j.1523-1755.2003.00160.x","article-title":"Fabry disease: detection of undiagnosed hemodialysis patients and identification of a \u201crenal variant\u201d phenotype","volume":"64","author":"Nakao","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.ymgme.2017.06.002_bb0030","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ymgmr.2015.05.006","article-title":"Late onset variants in Fabry disease: results in high risk population screenings in Argentina","volume":"4","author":"Serebrinsky","year":"2015","journal-title":"Mol Genet Metab Rep"},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2017.06.002_bb0035","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0009-8981(01)00478-8","article-title":"Fabry disease: enzymatic diagnosis in dried blood spots on filter paper","volume":"308","author":"Chamoles","year":"2001","journal-title":"Clin. Chim. Acta"},{"issue":"2","key":"10.1016\/j.ymgme.2017.06.002_bb0040","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1373\/clinchem.2014.225771","article-title":"Newborn screening for lysosomal storage diseases","volume":"61","author":"Gelb","year":"2015","journal-title":"Clin. Chem."},{"issue":"5","key":"10.1016\/j.ymgme.2017.06.002_bb0045","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1161\/CIRCGENETICS.109.862920","article-title":"High incidence of the cardiac variant of Fabry disease revealed by newborn screening in the Taiwan Chinese population","volume":"2","author":"Lin","year":"2009","journal-title":"Circ. Cardiovasc. Genet."},{"key":"10.1016\/j.ymgme.2017.06.002_bb0050","series-title":"High Incidence of Cardiac Variant of Fabry Disease in Taiwanese Revealed by Newborn Screening, in Taiwan Human Genetics Society Autumn Symposium","author":"KW","year":"2008"},{"key":"10.1016\/j.ymgme.2017.06.002_bb0055","doi-asserted-by":"crossref","first-page":"780","DOI":"10.2119\/molmed.2012.00002","article-title":"Fabry disease: incidence of the common later-onset alpha-galactosidase A IVS4+919G\u2192A mutation in Taiwanese newborns\u2014superiority of DNA-based to enzyme-based newborn screening for common mutations","volume":"18","author":"Chien","year":"2012","journal-title":"Mol. Med."},{"issue":"1","key":"10.1016\/j.ymgme.2017.06.002_bb0060","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1096-7192(02)00012-4","article-title":"Fabry disease: 45 novel mutations in the alpha-galactosidase A gene causing the classical phenotype","volume":"76","author":"Shabbeer","year":"2002","journal-title":"Mol. Genet. Metab."},{"issue":"5","key":"10.1016\/j.ymgme.2017.06.002_bb0065","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s10545-010-9166-7","article-title":"Enzyme assay and clinical assessment in subjects with a Chinese hotspot late-onset Fabry mutation (IVS4+919G\u2192A)","volume":"33","author":"Lin","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"issue":"4","key":"10.1016\/j.ymgme.2017.06.002_bb0070","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.ymgme.2012.01.010","article-title":"Fabry disease: biochemical, pathological and structural studies of the alpha-galactosidase A with E66Q amino acid substitution","volume":"105","author":"Togawa","year":"2012","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.ymgme.2017.06.002_bb0075","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.bbadis.2009.11.003","article-title":"Functional studies of new GLA gene mutations leading to conformational Fabry disease","volume":"1802","author":"Filoni","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.ymgme.2017.06.002_bb0080","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10545-011-9395-4","article-title":"Functional analysis of variant lysosomal acid glycosidases of Anderson-Fabry and Pompe disease in a human embryonic kidney epithelial cell line (HEK 293 T)","volume":"35","author":"Ebrahim","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"issue":"8","key":"10.1016\/j.ymgme.2017.06.002_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003632","article-title":"Functional characterisation of alpha-galactosidase A mutations as a basis for a new classification system in Fabry disease","volume":"9","author":"Lukas","year":"2013","journal-title":"PLoS Genet."},{"issue":"8","key":"10.1016\/j.ymgme.2017.06.002_bb0090","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1073\/pnas.0712309105","article-title":"Elevated globotriaosylsphingosine is a hallmark of Fabry disease","volume":"105","author":"Aerts","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.ymgme.2017.06.002_bb0095","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.bbrc.2010.08.006","article-title":"Tissue and plasma globotriaosylsphingosine could be a biomarker for assessing enzyme replacement therapy for Fabry disease","volume":"399","author":"Togawa","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.ymgme.2017.06.002_bb0100","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.bbadis.2010.09.007","article-title":"Reduction of elevated plasma globotriaosylsphingosine in patients with classic Fabry disease following enzyme replacement therapy","volume":"1812","author":"van Breemen","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"issue":"23\u201324","key":"10.1016\/j.ymgme.2017.06.002_bb0105","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1016\/j.cca.2010.07.038","article-title":"How well does urinary lyso-Gb3 function as a biomarker in Fabry disease?","volume":"411","author":"Auray-Blais","year":"2010","journal-title":"Clin. Chim. Acta"},{"issue":"9","key":"10.1016\/j.ymgme.2017.06.002_bb0110","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.bbadis.2010.05.003","article-title":"Plasma globotriaosylsphingosine: diagnostic value and relation to clinical manifestations of Fabry disease","volume":"1802","author":"Rombach","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"issue":"10","key":"10.1016\/j.ymgme.2017.06.002_bb0115","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1373\/clinchem.2008.104711","article-title":"Multiplex enzyme assay screening of dried blood spots for lysosomal storage disorders by using tandem mass spectrometry","volume":"54","author":"Zhang","year":"2008","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymgme.2017.06.002_bb0120","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.cca.2014.01.030","article-title":"Detecting multiple lysosomal storage diseases by tandem mass spectrometry\u2014a national newborn screening program in Taiwan","volume":"431","author":"Liao","year":"2014","journal-title":"Clin. Chim. Acta"},{"issue":"2","key":"10.1016\/j.ymgme.2017.06.002_bb0125","first-page":"157","article-title":"Fabry's disease: enzymatic diagnosis of hemizygotes and heterozygotes. Alpha-galactosidase activities in plasma, serum, urine, and leukocytes","volume":"81","author":"Desnick","year":"1973","journal-title":"J. Lab. Clin. Med."},{"issue":"2","key":"10.1016\/j.ymgme.2017.06.002_bb0130","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1042\/BJ20070479","article-title":"Mutant alpha-galactosidase A enzymes identified in Fabry disease patients with residual enzyme activity: biochemical characterization and restoration of normal intracellular processing by 1-deoxygalactonojirimycin","volume":"406","author":"Ishii","year":"2007","journal-title":"Biochem. J."},{"key":"10.1016\/j.ymgme.2017.06.002_bb0135","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.cca.2013.09.008","article-title":"Plasma globotriaosylsphingosine (lysoGb3) could be a biomarker for Fabry disease with a Chinese hotspot late-onset mutation (IVS4+919G>A)","volume":"426","author":"Liao","year":"2013","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/j.ymgme.2017.06.002_bb0140","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/CIRCGENETICS.113.000249","article-title":"Gene mutations versus clinically relevant phenotypes: lyso-Gb3 defines Fabry disease","volume":"7","author":"Niemann","year":"2014","journal-title":"Circ. Cardiovasc. Genet."},{"issue":"6","key":"10.1016\/j.ymgme.2017.06.002_bb0145","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJM199102073240607","article-title":"An atypical variant of Fabry's disease with manifestations confined to the myocardium","volume":"324","author":"von Scheidt","year":"1991","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.ymgme.2017.06.002_bb0150","doi-asserted-by":"crossref","first-page":"301","DOI":"10.5414\/CN108317","article-title":"A heterozygous female with Fabry disease due to a novel alpha-galactosidase A mutation exhibits a unique synaptopodin distribution in vacuolated podocytes","volume":"83","author":"Takahashi","year":"2015","journal-title":"Clin. Nephrol."},{"issue":"1","key":"10.1016\/j.ymgme.2017.06.002_bb0155","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/prot.24708","article-title":"Molecular damage in Fabry disease: characterization and prediction of alpha-galactosidase A pathological mutations","volume":"83","author":"Riera","year":"2015","journal-title":"Proteins"},{"issue":"5","key":"10.1016\/j.ymgme.2017.06.002_bb0160","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/1479-7364-2-5-297","article-title":"Fabry disease: identification of 50 novel alpha-galactosidase A mutations causing the classic phenotype and three-dimensional structural analysis of 29 missense mutations","volume":"2","author":"Shabbeer","year":"2006","journal-title":"Hum. Genomics"},{"issue":"9","key":"10.1016\/j.ymgme.2017.06.002_bb0165","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1093\/qjmed\/hcq117","article-title":"Fabry disease: a review of current management strategies","volume":"103","author":"Mehta","year":"2010","journal-title":"QJM"},{"key":"10.1016\/j.ymgme.2017.06.002_bb0170","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/8904_2012_154","article-title":"Lyso-Gb3 indicates that the alpha-galactosidase A mutation D313Y is not clinically relevant for Fabry disease","volume":"7","author":"Niemann","year":"2013","journal-title":"JIMD Rep"},{"issue":"3","key":"10.1016\/j.ymgme.2017.06.002_bb0175","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ymgme.2012.07.003","article-title":"Mutant alpha-galactosidase A with M296I does not cause elevation of the plasma globotriaosylsphingosine level","volume":"`107","author":"Mitobe","year":"2012","journal-title":"Mol. Genet. Metab."},{"issue":"4","key":"10.1016\/j.ymgme.2017.06.002_bb0180","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/jmedgenet-2014-102872","article-title":"Plasma globotriaosylsphingosine in relation to phenotypes of Fabry disease","volume":"52","author":"Smid","year":"2015","journal-title":"J. Med. Genet."},{"issue":"6","key":"10.1016\/j.ymgme.2017.06.002_bb0185","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1021\/ac203433e","article-title":"Urinary globotriaosylsphingosine-related biomarkers for Fabry disease targeted by metabolomics","volume":"84","author":"Auray-Blais","year":"2012","journal-title":"Anal. Chem."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719217301415?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719217301415?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,7]],"date-time":"2018-08-07T11:54:28Z","timestamp":1533642868000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719217301415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S1096719217301415"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2017.06.002","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functional and biological studies of \u03b1-galactosidase A variants with uncertain significance from newborn screening in Taiwan","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2017.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}